DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Trisenox (Arsenic Trioxide) - Current Clinical Trials

 
 



Trisenox Related Clinical Trials

Trisenox´┐Ż in Women With Metastatic Endometrial Cancer [Terminated]

Disulfiram Plus Arsenic Trioxide In Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy [Terminated]

Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery [Active, not recruiting]

Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia [Completed]

Study of Arsenic Trioxide in Small Cell Lung Cancer [Active, not recruiting]

Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients [Completed]

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Not yet recruiting]

Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC [Not yet recruiting]

A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver [Terminated]

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia [Terminated]

Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma [Enrolling by invitation]

Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia [Completed]

Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI [Recruiting]

Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction [Terminated]

Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma [Completed]

Arsenic Trioxide in Treating Patients With Urothelial Cancer [Completed]

Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes [Completed]

Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma [Active, not recruiting]

Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis [Active, not recruiting]

Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients [Completed]

Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma [Completed]

Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia [Recruiting]

Arsenic Trioxide for Induction Therapy of Adult Patients With Leukemia [Terminated]

Liposomal Doxorubicin, Vincristine, & Dexamethasone Plus Arsenic Trioxide in Untreated Symptomatic Multiple Myeloma [Completed]

Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder [Completed]

Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy [Active, not recruiting]

Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia [Completed]

Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia [Terminated]

A Phase II Trial of Trisenox Plus Thalomid as Treatment in Patients With Myelodysplastic Syndrome [Terminated]

A Leukemia SPORE Phase II Clinical Trial Comparing Decitabine Versus Decitabine/Carboplatin and Decitabine/Arsenic for the Treatment of Relapsed, Refractory, and Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) [Active, not recruiting]

Acute Promyelocytic Leukemia 2006 (APL) [Recruiting]

Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy [Terminated]

Bortezomib, Arsenic Trioxide, and Melphalan in Treating Patients Undergoing an Autologous Stem Cell Transplant For Multiple Myeloma [Withdrawn]

Acute Promyelocytic Leukemia (APL) Treated With ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin [Recruiting]

Phase 2a Study Evaluating the Arsenic Trioxide (ATO) in Systemic Lupus (SLE) (Protocol LUPSENIC) [Recruiting]

Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma [Terminated]

Trisenox, Ascorbic Acid and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma [Terminated]

Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML) [Recruiting]

Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia [Completed]

Phase II Research Study of Arsenic Trioxide (Trisenox) in Patients With Myelodysplastic Syndrome (MDS) [Terminated]

A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec [Completed]

Arsenic Trioxide in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Completed]

Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer [Withdrawn]

Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors [Completed]

Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia [Recruiting]

Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia [Completed]

Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma [Completed]

Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic Leukemia [Completed]

Low Dose Arsenic Trioxide as a Potential Chemotherapy Protector [Completed]

Cephalon Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndrome [Completed]

Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to Treatment [Completed]

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia [Active, not recruiting]

Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia [Terminated]

Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery [Completed]

Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO) [Completed]

Arsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Completed]

Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine [Completed]

Treatment of Non Promyelocytic Acute Myeloid Leukaemia on Elderly Patients by Low Dose Cytosar Plus Arsenic Trioxide [Completed]

Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia [Completed]

Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL [Recruiting]

Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas [Completed]

Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes [Terminated]

Pilot Trial of Arsenic + Cytarabine in Patients With Myelofibrosis [Active, not recruiting]

Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma [Withdrawn]

Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma [Completed]

Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma [Withdrawn]

Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes [Completed]

Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma [Completed]

Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes [Terminated]

Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia [Completed]

Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes [Terminated]

Arsenic Trioxide in Treating Patients With Advanced Solid Tumors [Completed]

Arsenic Trioxide in Treating Patients With Multiple Myeloma [Active, not recruiting]

Arsenic Trioxide in Treating Men With Germ Cell Cancer [Completed]

Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer [Completed]

Arsenic Trioxide in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Has Not Responded to Previous Treatment [Withdrawn]

Arsenic Trioxide in Treating Patients With Metastatic Kidney Cancer [Completed]

Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes [Active, not recruiting]

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Hodgkin's Disease [Terminated]

Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer [Completed]

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia [Completed]

Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia [Completed]

Arsenic Trioxide in Combination With Cytarabine in Patients With High-Risk MDS and Poor-Prognosis AML [Completed]

Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma [Completed]

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma [Completed]

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia [Completed]

Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy [Completed]

Arsenic Trioxide in Treating Patients With Refractory or Relapsed Chronic Lymphocytic Leukemia [Withdrawn]

Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma [Active, not recruiting]

New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia [Withdrawn]

Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma [Active, not recruiting]

Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic [Recruiting]

Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL [Completed]

Assessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070J [Completed]

Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia [Completed]

The Safety and Efficacy of 'AVI' Stent for Treating Coronary Revascularization [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015